|
|
| Activities |
 |
Goodman serves society through the development, manufacture, import, and
sale of products featuring the most advanced medical technology, mainly
in the field of cardiology. In the 1970s, Goodman was quick to notice the
great future potential of advanced medical technology that made its appearance
in the field of interventional cardiology for the diagnosis and treatment
of cardiovascular diseases. Since then, Goodman has committed itself in
the development and introduction of medical diagnostic equipment and treatment
instruments such as catheters, while at the same time developing Japan's
first software for heart function image analysis.
Goodman is unique in the field of catheters and related products, in that
we develop and introduce products responsive to user needs that are unique
to Japan based on the rich experience, knowledge and know-how we have accumulated
through our sales activities.
In recent years, we have also been actively developing and manufacturing
our own products, launching the Catheter Introducer, among others. Our
effort to respond to our users' needs continues.
Goodman continues to contribute to the enhancement of people's health by
providing the most advanced medical technology and products, focusing on
interventional cardiology. |
|
| Technological and Development Capabilities |
|
As pioneers in the field of cardiology, where rapid technological innovation
continues, we at Goodman continue to improve our technological and developmental
capabilities.
Goodman has developed and introduced the most advanced medical technology
in the field of cardiology, thereby establishing a new market. In the field
of diagnostic equipment, we have established new technologies and offer
products such as catheters that emit ultrasound waves to examine blood
vessel interiors; and a blood flow measuring device that uses Doppler ultrasound
signals. In the field of treatment instruments, we have marketed innovative
new devices developed with a vision unhindered by the notion of conventional
treatment tools. In the field of artificial organs, we have developed and
introduced artificial heart valves, as well as artificial blood vessels
using a new material (polyurethane), gradually broadening our market niche.
Developmental and technological innovations in medical care are progressing
quickly. We must promptly and accurately respond to the needs of the times.
Toward this end, we continue striving to upgrade the specialized knowledge
and technical skills of the Goodman staff. |
|
| Information Capability |
|
 We develop and introduce the most advanced medical technology and equipment
on the strength of our capability to gather the latest information from
overseas sources. Taking advantage of the international reputation we have
nurtured over many years, we tap a network of Japanese and international
physicians and specialists, and survey scientific journals and other sources
to acquire the latest information ahead of other companies, thereby enabling
our introduction of innovative and important medical technology. Such activities
of ours are highly praised by the Japanese medical community. |
|
|
| Future Potential |
|
The world's most advanced medical technology is moving towards less invasive,
safer, surer and faster diagnosis and treatment.
The greying of the Japanese population means a large increase in adult
health disorders is anticipated. At present, heart disease is the No. 3
cause of death in Japan, after cancer and cerebrovascular disease. Demand
is constantly growing for advanced medical technology that ensures better
diagnosis and treatment in cardiology. Goodman continues its effort to
develop and introduce medical technology that realizes less-invasive, safer,
more effective and more efficient diagnosis and treatment. We are also
determined to develop our own products and diversify our product lines
based on our rich knowledge, experience and know-how, making full use of
information obtained from overseas sources and closely responding to the
needs of the medical profession in Japan. Goodman promises further advances
in medical technology. |
|
